Clinical Ophthalmology (Aug 2021)
The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown
Abstract
Sahar Ashrafzadeh,1 Bradley S Gundlach,1 Irena Tsui2– 4 1David Geffen School of Medicine, University of California, Los Angeles, CA, USA; 2Ophthalmology Department, West Los Angeles Veterans Health Administration, Los Angeles, CA, USA; 3Retina Division, Stein Eye Institute, University of California, Los Angeles, CA, USA; 4Doheny Eye Institute, University of California, Los Angeles, CA, USACorrespondence: Irena Tsui Tel +1 310 825-7290Fax +1 310 825-9946Email [email protected]: Early on in the COVID-19 pandemic, it was difficult to know what factors would affect patient and physician decision-making regarding ophthalmic care utilization. The purpose of this study is to investigate the effect of non-ophthalmic factors on patient decision-making to receive intravitreal injections during the COVID-19 lockdown.Patients and Methods: Data on patients who had intravitreal injection appointments at a tertiary care Veterans Health Administration clinic during a seven-week period (March 19, 2020–May 8, 2020) of the COVID-19 outbreak in Los Angeles County were collected and compared to patients who had intravitreal injection appointments during the same time period in 2019. Demographic characteristics, injection diagnoses, visual acuities, body mass indices, co-morbidities, and psychiatric conditions of patients and clinic volumes were tabulated and compared between the two time periods.Results: There were 86 patients in the injection clinic in 2020 compared to 176 patients in 2019. The mean age and gender of patients in the injection clinic did not differ between 2019 and 2020. Compared to 2019, the number of patients who identified as Hispanic or Latino remained nearly the same, but the number of patients who identified as White, Black, or Asian or Pacific Islander decreased by nearly half. In 2020, a greater proportion of patients came to the injection clinic for neovascular age-related macular degeneration (56.5% vs 39.3%, p=0.017), but a decreased proportion of patients diagnosed with a heart condition (OR 0.57, 95% CI 0.33, 0.96), chronic obstructive pulmonary disease (OR 0.43, 95% CI 0.21, 0.91), or asthma (OR 0.09, 95% CI 0.01, 0.70) came to the injection clinic.Conclusion: The COVID-19 pandemic was associated with behavioral changes in eyecare utilization influenced by race and systemic co-morbidities. These data can be used to design and implement strategies to address disparities in essential ophthalmic care among vulnerable populations.Keywords: anti-vascular endothelial growth factor, co-morbidities, coronavirus disease 2019, disparities, neovascular age-related macular degeneration, retina
